<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23959904</PMID><DateCompleted><Year>2013</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1091-6490</ISSN><JournalIssue CitedMedium="Internet"><Volume>110</Volume><Issue>36</Issue><PubDate><Year>2013</Year><Month>Sep</Month><Day>03</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Transgenic mouse model for the study of enterovirus 71 neuropathogenesis.</ArticleTitle><Pagination><StartPage>14753</StartPage><EndPage>14758</EndPage><MedlinePgn>14753-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.1217563110</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV71) typically causes mild hand-foot-and-mouth disease in children, but it can also cause severe neurological disease. Recently, epidemic outbreaks of EV71 with significant mortality have been reported in the Asia-Pacific region, and EV71 infection has become a serious public health concern worldwide. However, there is little information available concerning EV71 neuropathogenesis, and no vaccines or anti-EV71 drugs have been developed. Previous studies of this disease have used monkeys and neonatal mice that are susceptible to some EV71 strains as models. The monkey model is problematic for ethical and economical reasons, and mice that are more than a few weeks old lose their susceptibility to EV71. Thus, the development of an appropriate small animal model would greatly contribute to the study of this disease. Mice lack EV71 susceptibility due to the absence of a receptor for this virus. Previously, we identified the human scavenger receptor class B, member 2 (hSCARB2) as a cellular receptor for EV71. In the current study, we generated a transgenic (Tg) mouse expressing hSCARB2 with an expression profile similar to that in humans. Tg mice infected with EV71 exhibited ataxia, paralysis, and death. The most severely affected cells were neurons in the spinal cord, brainstem, cerebellum, hypothalamus, thalamus, and cerebrum. The pathological features in these Tg mice were generally similar to those of EV71 encephalomyelitis in humans and experimentally infected monkeys. These results suggest that this Tg mouse could represent a useful animal model for the study of EV71 infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fujii</LastName><ForeName>Ken</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Neurovirology Project, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagata</LastName><ForeName>Noriyo</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Sato</LastName><ForeName>Yuko</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Ong</LastName><ForeName>Kien Chai</ForeName><Initials>KC</Initials></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Kum Thong</ForeName><Initials>KT</Initials></Author><Author ValidYN="Y"><LastName>Yamayoshi</LastName><ForeName>Seiya</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Shimanuki</LastName><ForeName>Midori</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Shitara</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Taya</LastName><ForeName>Choji</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Koike</LastName><ForeName>Satoshi</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>08</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051907">Lysosomal Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051116">Receptors, Scavenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C074299">SCARB2 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002493" MajorTopicYN="N">Central Nervous System Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="Y">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054884" MajorTopicYN="N">Host-Pathogen Interactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051907" MajorTopicYN="N">Lysosomal Membrane Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051116" MajorTopicYN="N">Receptors, Scavenger</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">neurotropism</Keyword><Keyword MajorTopicYN="N">picornavirus</Keyword><Keyword MajorTopicYN="N">viral receptor</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2014</Year><Month>3</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23959904</ArticleId><ArticleId IdType="pmc">PMC3767555</ArticleId><ArticleId IdType="doi">10.1073/pnas.1217563110</ArticleId><ArticleId IdType="pii">1217563110</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schmidt NJ, Lennette EH, Ho HH. An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis. 1974;129(3):304&#x2013;309.</Citation><ArticleIdList><ArticleId IdType="pubmed">4361245</ArticleId></ArticleIdList></Reference><Reference><Citation>Pallansch M, Roos R (2007) Enteroviruses: Polioviruses, Coxsackieviruses, Echoviruses, and newer Enteroviruses. Fields Virology, eds Knipe DM et al. (Lippincott Williams &amp; Wilkins, Philadelphia), 5th Ed, Vol 1, pp 839&#x2013;893.</Citation></Reference><Reference><Citation>Ho M, et al. Taiwan Enterovirus Epidemic Working Group An epidemic of enterovirus 71 infection in Taiwan. N Engl J Med. 1999;341(13):929&#x2013;935.</Citation><ArticleIdList><ArticleId IdType="pubmed">10498487</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang CC, et al. Neurologic complications in children with enterovirus 71 infection. N Engl J Med. 1999;341(13):936&#x2013;942.</Citation><ArticleIdList><ArticleId IdType="pubmed">10498488</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong KT, et al. Enterovirus 71 encephalomyelitis and Japanese encephalitis can be distinguished by topographic distribution of inflammation and specific intraneuronal detection of viral antigen and RNA. Neuropathol Appl Neurobiol. 2012;38(5):443&#x2013;453.</Citation><ArticleIdList><ArticleId IdType="pubmed">22236252</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong KT, et al. The distribution of inflammation and virus in human enterovirus 71 encephalomyelitis suggests possible viral spread by neural pathways. J Neuropathol Exp Neurol. 2008;67(2):162&#x2013;169.</Citation><ArticleIdList><ArticleId IdType="pubmed">18219253</ArticleId></ArticleIdList></Reference><Reference><Citation>Shindarov LM, et al. Epidemiological, clinical, and pathomorphological characteristics of epidemic poliomyelitis-like disease caused by enterovirus 71. J Hyg Epidemiol Microbiol Immunol. 1979;23(3):284&#x2013;295.</Citation><ArticleIdList><ArticleId IdType="pubmed">231067</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagy G, Tak&#xe1;tsy S, Kuk&#xe1;n E, Mih&#xe1;ly I, D&#xf6;m&#xf6;k I. Virological diagnosis of enterovirus type 71 infections: Experiences gained during an epidemic of acute CNS diseases in Hungary in 1978. Arch Virol. 1982;71(3):217&#x2013;227.</Citation><ArticleIdList><ArticleId IdType="pubmed">6285858</ArticleId></ArticleIdList></Reference><Reference><Citation>AbuBakar S, et al. Identification of enterovirus 71 isolates from an outbreak of hand, foot and mouth disease (HFMD) with fatal cases of encephalomyelitis in Malaysia. Virus Res. 1999;61(1):1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">10426204</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, et al. Hand, foot, and mouth disease in China: Patterns of spread and transmissibility. Epidemiology. 2011;22(6):781&#x2013;792.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3246273</ArticleId><ArticleId IdType="pubmed">21968769</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto I, Hagiwara A, Kodama H. Neurovirulence in cynomolgus monkeys of enterovirus 71 isolated from a patient with hand, foot and mouth disease. Arch Virol. 1978;56(3):257&#x2013;261.</Citation><ArticleIdList><ArticleId IdType="pubmed">205198</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto I, Hagiwara A. Studies on the pathogenesis of and propagation of enterovirus 71 in Poliomyelitis-like disease in monkeys. Acta Neuropathol. 1982;58(2):125&#x2013;132.</Citation><ArticleIdList><ArticleId IdType="pubmed">6758469</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto I, Hagiwara A. Pathogenicity of a poliomyelitis-like disease in monkeys infected orally with enterovirus 71: A model for human infection. Neuropathol Appl Neurobiol. 1982;8(2):149&#x2013;156.</Citation><ArticleIdList><ArticleId IdType="pubmed">7048123</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagata N, et al. Pyramidal and extrapyramidal involvement in experimental infection of cynomolgus monkeys with enterovirus 71. J Med Virol. 2002;67(2):207&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">11992581</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagata N, et al. Differential localization of neurons susceptible to enterovirus 71 and poliovirus type 1 in the central nervous system of cynomolgus monkeys after intravenous inoculation. J Gen Virol. 2004;85(Pt 10):2981&#x2013;2989.</Citation><ArticleIdList><ArticleId IdType="pubmed">15448361</ArticleId></ArticleIdList></Reference><Reference><Citation>Chumakov M, et al. Enterovirus 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria. Arch Virol. 1979;60(3-4):329&#x2013;340.</Citation><ArticleIdList><ArticleId IdType="pubmed">228639</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YC, et al. A murine oral enterovirus 71 infection model with central nervous system involvement. J Gen Virol. 2004;85(Pt 1):69&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">14718621</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YF, et al. A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. J Virol. 2004;78(15):7916&#x2013;7924.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC446098</ArticleId><ArticleId IdType="pubmed">15254164</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, et al. A mouse muscle-adapted enterovirus 71 strain with increased virulence in mice. Microbes Infect. 2011;13(10):862&#x2013;870.</Citation><ArticleIdList><ArticleId IdType="pubmed">21612764</ArticleId></ArticleIdList></Reference><Reference><Citation>Khong WX, et al. A non-mouse-adapted enterovirus 71 (EV71) strain exhibits neurotropism, causing neurological manifestations in a novel mouse model of EV71 infection. J Virol. 2012;86(4):2121&#x2013;2131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3302383</ArticleId><ArticleId IdType="pubmed">22130542</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergelson JM. Receptors. In: Ehrenfeld E, Domingo E, Roos RP, editors. The Picornaviruses. Washington, DC: ASM Press; 2010. pp. 73&#x2013;86.</Citation></Reference><Reference><Citation>Ren RB, Costantini F, Gorgacz EJ, Lee JJ, Racaniello VR. Transgenic mice expressing a human poliovirus receptor: A new model for poliomyelitis. Cell. 1990;63(2):353&#x2013;362.</Citation><ArticleIdList><ArticleId IdType="pubmed">2170026</ArticleId></ArticleIdList></Reference><Reference><Citation>Koike S, et al. Transgenic mice susceptible to poliovirus. Proc Natl Acad Sci USA. 1991;88(3):951&#x2013;955.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC50932</ArticleId><ArticleId IdType="pubmed">1846972</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartlett NW, et al. Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation. Nat Med. 2008;14(2):199&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3384678</ArticleId><ArticleId IdType="pubmed">18246079</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B, Chuang H, Yang KD. Sialylated glycans as receptor and inhibitor of enterovirus 71 infection to DLD-1 intestinal cells. Virol J. 2009;6:141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2751754</ArticleId><ArticleId IdType="pubmed">19751532</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang SL, Chou YT, Wu CN, Ho MS. Annexin II binds to capsid protein VP1 of enterovirus 71 and enhances viral infectivity. J Virol. 2011;85(22):11809&#x2013;11820.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3209289</ArticleId><ArticleId IdType="pubmed">21900167</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y, et al. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med. 2009;15(7):794&#x2013;797.</Citation><ArticleIdList><ArticleId IdType="pubmed">19543284</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, et al. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med. 2009;15(7):798&#x2013;801.</Citation><ArticleIdList><ArticleId IdType="pubmed">19543282</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuronita T, et al. A role for the lysosomal membrane protein LGP85 in the biogenesis and maintenance of endosomal and lysosomal morphology. J Cell Sci. 2002;115(Pt 21):4117&#x2013;4131.</Citation><ArticleIdList><ArticleId IdType="pubmed">12356916</ArticleId></ArticleIdList></Reference><Reference><Citation>Reczek D, et al. LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase. Cell. 2007;131(4):770&#x2013;783.</Citation><ArticleIdList><ArticleId IdType="pubmed">18022370</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Koike S. Identification of a human SCARB2 region that is important for enterovirus 71 binding and infection. J Virol. 2011;85(10):4937&#x2013;4946.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3126200</ArticleId><ArticleId IdType="pubmed">21389126</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, et al. Human SCARB2-dependent infection by coxsackievirus A7, A14, and A16 and enterovirus 71. J Virol. 2012;86(10):5686&#x2013;5696.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3347270</ArticleId><ArticleId IdType="pubmed">22438546</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Ohka S, Fujii K, Koike S. Functional comparison of SCARB2 and PSGL1 as receptors for enterovirus 71. J Virol. 2013;87(6):3335&#x2013;3347.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3592140</ArticleId><ArticleId IdType="pubmed">23302872</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabuchi N, Akasaki K, Sasaki T, Kanda N, Tsuji H. Identification and characterization of a major lysosomal membrane glycoprotein, LGP85/LIMP II in mouse liver. J Biochem. 1997;122(4):756&#x2013;763.</Citation><ArticleIdList><ArticleId IdType="pubmed">9399579</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamp AC, et al. LIMP-2/LGP85 deficiency causes ureteric pelvic junction obstruction, deafness and peripheral neuropathy in mice. Hum Mol Genet. 2003;12(6):631&#x2013;646.</Citation><ArticleIdList><ArticleId IdType="pubmed">12620969</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritsch A, et al. Molecular characterization of rabbit scavenger receptor class B types I and II: Portal to central vein gradient of expression in the liver. J Lipid Res. 2004;45(2):214&#x2013;222.</Citation><ArticleIdList><ArticleId IdType="pubmed">14595001</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, et al. Transgenic expression of human P-selectin glycoprotein ligand-1 is not sufficient for enterovirus 71 infection in mice. Arch Virol. 2012;157(3):539&#x2013;543.</Citation><ArticleIdList><ArticleId IdType="pubmed">22187102</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranzenhofer ER, Dizon FC, Lipton MM, Steigman AJ. Clinical paralytic poliomyelitis due to Coxsackie virus group A, type 7. N Engl J Med. 1958;259(4):182.</Citation><ArticleIdList><ArticleId IdType="pubmed">13566445</ArticleId></ArticleIdList></Reference><Reference><Citation>Helin I, Widell A, Borulf S, Walder M, Ulmsten U. Outbreak of coxsackievirus A-14 meningitis among newborns in a maternity hospital ward. Acta Paediatr Scand. 1987;76(2):234&#x2013;238.</Citation><ArticleIdList><ArticleId IdType="pubmed">3035861</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu W, et al. Distribution of enteroviruses in hospitalized children with hand, foot and mouth disease and relationship between pathogens and nervous system complications. Virol J. 2012;9(1):8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3268717</ArticleId><ArticleId IdType="pubmed">22230340</ArticleId></ArticleIdList></Reference><Reference><Citation>Samuda GM, Chang WK, Yeung CY, Tang PS. Monoplegia caused by Enterovirus 71: An outbreak in Hong Kong. Pediatr Infect Dis J. 1987;6(2):206&#x2013;208.</Citation><ArticleIdList><ArticleId IdType="pubmed">3562141</ArticleId></ArticleIdList></Reference><Reference><Citation>Melnick JL. Enterovirus type 71 infections: A varied clinical pattern sometimes mimicking paralytic poliomyelitis. Rev Infect Dis. 1984;6(Suppl 2):S387&#x2013;S390.</Citation><ArticleIdList><ArticleId IdType="pubmed">6330839</ArticleId></ArticleIdList></Reference><Reference><Citation>Lum LC, et al. Fatal enterovirus 71 encephalomyelitis. J Pediatr. 1998;133(6):795&#x2013;798.</Citation><ArticleIdList><ArticleId IdType="pubmed">9842048</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SM, et al. Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications. Clin Infect Dis. 1999;29(1):184&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pubmed">10433583</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong C, et al. Immunoprotection elicited by an enterovirus type 71 experimental inactivated vaccine in mice and rhesus monkeys. Vaccine. 2011;29(37):6269&#x2013;6275.</Citation><ArticleIdList><ArticleId IdType="pubmed">21722686</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang JY, et al. Selection and characterization of vaccine strain for Enterovirus 71 vaccine development. Vaccine. 2012;30(4):703&#x2013;711.</Citation><ArticleIdList><ArticleId IdType="pubmed">22142585</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong KC, Devi S, Cardosa MJ, Wong KT. Formaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against disease. J Virol. 2010;84(1):661&#x2013;665.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2798416</ArticleId><ArticleId IdType="pubmed">19864378</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YW, et al. Human SCARB2 transgenic mice as an infectious animal model for enterovirus 71. PLoS ONE. 2013;8(2):e57591.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3581494</ArticleId><ArticleId IdType="pubmed">23451246</ArticleId></ArticleIdList></Reference><Reference><Citation>Koike S, et al. Characterization of three different transgenic mouse lines that carry human poliovirus receptor gene&#x2014;influence of the transgene expression on pathogenesis. Arch Virol. 1994;139(3-4):351&#x2013;363.</Citation><ArticleIdList><ArticleId IdType="pubmed">7832641</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe S, et al. Studies on neurovirulence in poliovirus-sensitive transgenic mice and cynomolgus monkeys for the different temperature-sensitive viruses derived from the Sabin type 3 virus. Virology. 1995;210(1):160&#x2013;166.</Citation><ArticleIdList><ArticleId IdType="pubmed">7793068</ArticleId></ArticleIdList></Reference><Reference><Citation>Horie H, et al. Transgenic mice carrying the human poliovirus receptor: New animal models for study of poliovirus neurovirulence. J Virol. 1994;68(2):681&#x2013;688.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC236503</ArticleId><ArticleId IdType="pubmed">8289371</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe S, et al. Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice. Virology. 1995;206(2):1075&#x2013;1083.</Citation><ArticleIdList><ArticleId IdType="pubmed">7856082</ArticleId></ArticleIdList></Reference><Reference><Citation>Dragunsky E, et al. Transgenic mice as an alternative to monkeys for neurovirulence testing of live oral poliovirus vaccine: Validation by a WHO collaborative study. Bull World Health Organ. 2003;81(4):251&#x2013;260.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2572431</ArticleId><ArticleId IdType="pubmed">12764491</ArticleId></ArticleIdList></Reference><Reference><Citation>Kew O, et al. Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science. 2002;296(5566):356&#x2013;359.</Citation><ArticleIdList><ArticleId IdType="pubmed">11896235</ArticleId></ArticleIdList></Reference><Reference><Citation>Jegouic S, et al. Recombination between polioviruses and co-circulating Coxsackie A viruses: Role in the emergence of pathogenic vaccine-derived polioviruses. PLoS Pathog. 2009;5(5):e1000412.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2669712</ArticleId><ArticleId IdType="pubmed">19412342</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu H, et al. Enterovirus 71 from fatal and nonfatal cases of hand, foot and mouth disease epidemics in Malaysia, Japan and Taiwan in 1997-1998. Jpn J Infect Dis. 1999;52(1):12&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">10808253</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu H, et al. Molecular epidemiology of enterovirus 71 infection in the Western Pacific Region. Pediatr Int. 2004;46(2):231&#x2013;235.</Citation><ArticleIdList><ArticleId IdType="pubmed">15056257</ArticleId></ArticleIdList></Reference><Reference><Citation>Sickles GM, Mutterer M, Feorino P, Plager H. Recently classified types of Coxsackie virus, group A: Behavior in tissue culture. Proc Soc Exp Biol Med. 1955;90(2):529&#x2013;531.</Citation><ArticleIdList><ArticleId IdType="pubmed">13273503</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>